Total Payments
$5,508
2024 Payments
$371.38
Companies
21
Transactions
90
Medicare Patients
137
Medicare Billing
$28,460
Payment Breakdown by Category
Food & Beverage$5,508 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,508 | 90 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,639 | 26 | $0 (2024) |
| Novo Nordisk Inc | $1,235 | 23 | $0 (2024) |
| Lilly USA, LLC | $496.71 | 11 | $0 (2024) |
| Watermark Medical, Inc. | $256.21 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $245.53 | 3 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $207.76 | 5 | $0 (2024) |
| Allergan Inc. | $166.06 | 3 | $0 (2019) |
| ABBVIE INC. | $154.72 | 2 | $0 (2024) |
| Ethicon Inc. | $147.58 | 1 | $0 (2022) |
| Penumbra, Inc. | $133.80 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371.38 | 13 | Bayer Healthcare Pharmaceuticals Inc. ($188.48) |
| 2023 | $186.03 | 4 | Lilly USA, LLC ($137.30) |
| 2022 | $980.28 | 17 | AstraZeneca Pharmaceuticals LP ($317.86) |
| 2021 | $1,221 | 14 | Novo Nordisk Inc ($482.67) |
| 2020 | $974.27 | 14 | AstraZeneca Pharmaceuticals LP ($744.67) |
| 2019 | $202.71 | 6 | AstraZeneca Pharmaceuticals LP ($149.53) |
| 2018 | $626.35 | 5 | Penumbra, Inc. ($133.80) |
| 2017 | $945.87 | 17 | Novo Nordisk Inc ($416.68) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Cardio-renal | ||||||
| 10/31/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Endovascular | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardio-renal | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Cardio-renal | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Gastroenterology | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 09/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Diabetes | ||||||
| 06/16/2023 | Watermark Medical, Inc. | ARES HOME SLEEP TESTING DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $26.61 | General |
| Category: VENTILATORY EFFORT RECORDER | ||||||
| 05/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $121.82 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 10/05/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $147.58 | General |
| Category: Endo-Mechanical | ||||||
| 09/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $120.74 | General |
| Category: Diabetes | ||||||
| 08/03/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Diabetes | ||||||
| 07/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $114.75 | General |
| Category: Diabetes | ||||||
| 07/20/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Diabetes | ||||||
| 06/23/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $70.80 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 52 | $11,800 | $3,697 |
| 2022 | 2 | 35 | 67 | $18,390 | $5,930 |
| 2021 | 1 | 28 | 96 | $25,920 | $8,103 |
| 2020 | 2 | 45 | 134 | $36,420 | $10,730 |
Total Patients
137
Total Services
349
Medicare Billing
$28,460
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 36 | $9,720 | $2,626 | 27.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 14 | 16 | $2,080 | $1,071 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 52 | $14,040 | $3,980 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $4,350 | $1,950 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 96 | $25,920 | $8,103 | 31.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 122 | $32,940 | $9,374 | 28.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $3,480 | $1,356 | 39.0% |
About Dr. Ramon Sanchez, M.D
Dr. Ramon Sanchez, M.D is a General Practice healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1801194147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramon Sanchez, M.D has received a total of $5,508 in payments from pharmaceutical and medical device companies, with $371.38 received in 2024. These payments were reported across 90 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,508).
As a Medicare-enrolled provider, Sanchez has provided services to 137 Medicare beneficiaries, totaling 349 services with total Medicare billing of $28,460. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties General Practice, General Practice
- Location Tampa, FL
- Active Since 03/10/2011
- Last Updated 05/12/2020
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801194147
Products in Payments
- BREZTRI (Drug) $688.82
- FARXIGA (Drug) $688.55
- Ozempic (Drug) $443.78
- Tresiba (Drug) $339.11
- MOUNJARO (Drug) $308.03
- ENTRESTO (Drug) $245.53
- RYBELSUS (Drug) $231.70
- Kerendia (Drug) $188.48
- TRULICITY (Drug) $174.02
- Monarch Platform (Device) $147.58
- Rybelsus (Drug) $142.86
- NAMENDA XR (Drug) $139.42
- Penumbra SMART Coil (Device) $133.80
- NEXLIZET (Drug) $124.99
- QULIPTA (Drug) $124.98
- BREZTRI AEROSPHERE (Drug) $124.88
- Vascepa (Drug) $123.83
- Impella (Device) $123.66
- Repatha (Biological) $121.86
- TRELEGY ELLIPTA (Drug) $117.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Tampa
Dr. Sarah Jockin, Dds, DDS
General Practice — Payments: $366,051
General Practice $366,051
Dr. William Torres Perez, M.d, M.D
General Practice — Payments: $82,552
General Practice $82,552
Jeffrey Hunt, Do, DO
General Practice — Payments: $76,793
General Practice $76,793
Dr. David Goldschein, D.d.s, D.D.S
General Practice — Payments: $25,125
General Practice $25,125
Dr. Jorge Diaz, M.d, M.D
General Practice — Payments: $16,738
General Practice $16,738
Dr. Matthew Waite, D.d.s, D.D.S
General Practice — Payments: $15,978
General Practice $15,978